2023 trends: Psychedelic medications see open doors in clinical research
As we look toward the New Year, those of us in the clinical trial field are thinking about the next big… Read More
2023 trends: Psychedelic medications see open doors in clinical research
As we look toward the New Year, those of us in the clinical trial field are thinking about the next big… Read More
Principal Investigator shares thoughts on TrueBinding Alzheimer’s trial
TrueBinding recently released results of a Phase 1b/2 trial for TB006, which showed improvements for patients with mild to severe Alzheimer’s… Read More
New Methods of Detection for Parkinson’s
Parkinson’s disease affects up to a million Americans, and doctors diagnose 60,000 new cases each year. It is the second most… Read More
Q&A for National Depression Education and Awareness Month
You might not realize it, but October shines a big spotlight on mental health. The month features several mental-health-related awareness celebrations,… Read More
Accel Research Sites recruiting smokers for cessation study
To say it’s been another groundbreaking year in healthcare is an understatement. Worldwide, people continued the battle against COVID-19, and healthcare… Read More
By the numbers: How Accel Research Sites grew in 2021
By the numbers: How Accel Research Sites grew in 2021 Read More
COVID-19 Vaccines for Children: What We Saw in Clinical Trials
Alzheimer’s Awareness Month: What Accel is doing to help now and in the future Read More
Alzheimer’s Awareness Month: What Accel is doing to help now and in the future
If you or a loved one has ever faced an Alzheimer’s Disease diagnosis, you know how scary it can be. Read More